BLOG purpose

This BLOG is for LLNL present and past employees, friends of LLNL and anyone impacted by the privatization of the Lab to express their opinions and expose the waste, wrongdoing and any kind of injustice against employees and taxpayers by LLNS/DOE/NNSA. The opinions stated are personal opinions. Therefore, The BLOG author may or may not agree with them before making the decision to post them. Comments not conforming to BLOG rules are deleted. Blog author serves as a moderator. For new topics or suggestions, email


  • Stay on topic.
  • No foul, vulgar, or inflammatory language.
  • No name calling.
  • No personal attacks or put-downs of other blog users.
  • Be patient. Moderator checks and approves new posts several times a day.

Suggest new topics here


Submit candidates for new topics here only. Stay on topic with National Labs' related issues. All submissions are screened first for ...

Saturday, December 10, 2016

Trump's 74 questions sent to DOE:

Full list of Trump's 74 questions sent to DOE:


Anonymous said...

Interesting. Whoever did the asking knows little about the DOE bureaucracy.

Anonymous said...

Said like a true bureaucrat. Whomever did the asking only needs to know one thing about bureaucracy: there is too much of it and heads need to roll.

Anonymous said...

74 questions to DOE and not one on its nuclear weapons program - which is over 40% of DOE's budget. Trump doesn't even know what DOE does. Take about zero intellectual curiosity among this incoming administration.

Anonymous said...

Here are the ones they should push on:
61 - Is there a readily available list of any technologies or products that have emerged from DOE S4 programs or the labs that are currently offered in the market without any subsidy?
It would be great to see the DOE labs pushed to do practical development. Maybe the LDRD tax could be converted into commercialization funds to encourage us to work with companies.

Anonymous said...

Companies don't want to work with the labs, because the labs are too expensive and too risky, and because the paperwork burden is enormous. It takes special unusual circumstances for commercial partnerships to make sense to the commercial partners, and no amount of money shuffling and incentivization at the labs will change that.

Posts you viewed tbe most last 30 days